DEFA14A: Psychemedics Corporation Amends Proxy Statement Regarding Adjournment Proposal

Psychemedics Corporation has issued a supplement to its proxy statement clarifying that the adjournment proposal is considered a routine matter by the NYSE, allowing brokers discretionary voting.

Summary

• Psychemedics Corporation has released a supplement to its previously filed proxy statement.
• This supplement clarifies that Proposal 7, concerning the adjournment of the Annual Meeting, is considered a routine matter by the New York Stock Exchange (NYSE).
• The NYSE's designation allows brokers to vote on this proposal at their discretion if shareholders do not provide specific instructions.
• The company does not anticipate any broker non-votes on the adjournment proposal due to this classification.

Sentiment

Score: 7

Explanation: The document is a procedural update, not a major event, and is neutral to slightly positive as it clarifies the voting process.

Positives

• The clarification from the NYSE simplifies the voting process for the adjournment proposal.
• The company anticipates a smoother voting process with fewer non-votes.

Risks

• Shareholders who do not provide voting instructions may have their shares voted at the discretion of their brokers.

Industry Context

This announcement is specific to the company's proxy voting process and does not reflect broader industry trends.

Stakeholder Impact

• Shareholders are impacted by the clarification of the voting process.
• Brokers are impacted by the ability to exercise discretionary voting.

Next Steps

• Shareholders should review the supplement and the original proxy statement before the annual meeting.
• Shareholders should provide voting instructions to their brokers if they wish to direct how their shares are voted on the adjournment proposal.

Key Dates

Keywords

proxy statement, Psychemedics, NYSE, adjournment proposal, discretionary voting, annual meeting, broker non-votes